Marc Dunoyer
Chief Executive Officer at ALEXION PHARMACEUTICALS, INC.
Network origin in Marc Dunoyer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
125
| Public Company | Pharmaceuticals: Major | 125 |
54
| Public Company | Pharmaceuticals: Major | 54 |
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Subsidiary | Pharmaceuticals: Major | 14 | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.
11
| Subsidiary | Biotechnology | 11 |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands.
4
| Subsidiary | Pharmaceuticals: Generic | 4 |
Astrazeneca Intermediate Holdings Ltd.
 Astrazeneca Intermediate Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Intermediate Holdings Ltd. operates as a British intermediate holding company through its subsidiaries and researches, manufactures, and markets pharmaceuticals. The company is based in Cambridge, UK.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan
3
| Subsidiary | Household/Personal Care | 3 |
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marc Dunoyer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | President Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| PRUDENTIAL PLC | Life/Health Insurance | Director of Finance/CFO Chairman | |
| ERICSSON | Telecommunications Equipment | Chairman Director/Board Member | |
| DIAGEO PLC | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director/Board Member Independent Dir/Board Member Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
| VODAFONE GROUP PLC | Wireless Telecommunications | Director/Board Member Director/Board Member | |
| UBS | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| STANDARD CHARTERED PLC | Major Banks | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Human Resources Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| ELECTROLUX AB | Electronics/Appliances | Chief Executive Officer Chairman | |
| Knut och Alice Wallenbergs Stiftelse | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Director/Board Member Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Chalmers University of Technology | College/University | Graduate Degree Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Undergraduate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal President | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member President General Counsel | |
| CARMAT | Medical Specialties | Chairman Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
The 100 Group
 The 100 Group Miscellaneous Commercial ServicesCommercial Services The 100 Group is an organization that represents the views of finance directors from FTSE 100 and several large UK private companies. The private company is based in London, UK. The group is structured through committees that meet quarterly to discuss emerging topics on the agenda of finance directors. The main objective of the 100 Group is to promote the competitiveness of businesses. | Miscellaneous Commercial Services | Chairman Chairman | |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | Director/Board Member President Chief Executive Officer |
Statistics
International
| United States | 24 |
| United Kingdom | 12 |
| France | 9 |
| Sweden | 7 |
| Switzerland | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 13 |
| Finance | 5 |
| Commercial Services | 5 |
| Consumer Non-Durables | 3 |
Operational
| Director/Board Member | 548 |
| Corporate Officer/Principal | 182 |
| Independent Dir/Board Member | 180 |
| Chairman | 125 |
| Chief Executive Officer | 80 |
Most connected contacts
| Insiders | |
|---|---|
| Anjali Bansal | 37 |
| Marcus Wallenberg | 34 |
| James Murdoch | 32 |
| Simon Dingemans | 31 |
| Pierre Bastid | 29 |
| Lynn Elsenhans | 28 |
| Jean-Pierre Garnier | 28 |
| Briggs Morrison | 26 |
| Sherilyn McCoy | 26 |
| Charles Rowland | 25 |
| James Geraghty | 25 |
| Philip Broadley | 24 |
| Geneviéve B. Berger | 23 |
| Leif Valdemar Johansson | 21 |
| H. Culp | 21 |
- Stock Market
- Insiders
- Marc Dunoyer
- Company connections
